GLYMPHATIC RESERVE AS A DETERMINANT OF RESPONSIVENESS NEURO-METABOLIC REHABILITATION DRIVEN BY GLP-1 RECEPTOR AGONISTS: A NOVEL PARADIGM FOR MANAGING ALZHEIMER’S DISEASE AS TYPE 3 DIABETES IN CENTRAL ASIA
Sayat Oraz; Gulmira Abdikarimova; Yerzhan Uteuliev